HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Curative potential of multimodality therapy for locally recurrent rectal cancer.

AbstractOBJECTIVE:
To assess the results of multimodality therapy for patients with recurrent rectal cancer and to analyze factors predictive of curative resection and prognostic for overall survival.
SUMMARY BACKGROUND DATA:
Locally recurrent rectal cancer is a difficult clinical problem, and radical treatment options with curative intent are not generally accepted.
METHODS:
A total of 394 patients underwent surgical exploration for recurrent rectal cancer. Ninety were found to have unresectable local or extrapelvic disease and 304 underwent resection of the recurrence. The latter patients were prospectively followed to determine long-term survival and factors influencing survival.
RESULTS:
Overall 5-year survival was 25%. Curative, negative resection margins were obtained in 45% of patients; in these patients a 5-year survival of 37% was achieved, compared to 16% (P <.001) in patients with either microscopic or gross residual disease. In a logistic regression analysis, initial surgery with end-colostomy and symptomatic pain (both univariate) and increasing number of sites of the recurrent tumor fixation in the pelvis (multivariate) were associated with palliative surgery. Overall survival was significantly decreased for symptomatic pain (P <.001) and more than one fixation (P =.029). Survival following extended resection of adjacent organs was not different from limited resection (28% vs. 21%, P =.11). Patient demographics and factors related to the initial rectal cancer did not affect outcome. Perioperative mortality was only 0.3%, but significant morbidity occurred in 26% of patients, with pelvic abscess being the most common complication.
CONCLUSIONS:
This study demonstrates that many patients with locally recurrent rectal cancer can be resected with negative margins. Long-term survival can be achieved, especially for patients with no symptoms and minimal fixation of the recurrence in the pelvis, provided no gross residual disease remains.
AuthorsDieter Hahnloser, Heidi Nelson, Leonard L Gunderson, Imran Hassan, Michael G Haddock, Michael J O'Connell, Stephen Cha, Daniel J Sargent, Alan Horgan
JournalAnnals of surgery (Ann Surg) Vol. 237 Issue 4 Pg. 502-8 (Apr 2003) ISSN: 0003-4932 [Print] United States
PMID12677146 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Female
  • Humans
  • Intraoperative Period
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy, mortality, radiotherapy, surgery)
  • Postoperative Complications (epidemiology)
  • Prognosis
  • Prospective Studies
  • Rectal Neoplasms (drug therapy, mortality, radiotherapy, surgery)
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: